John Higgins

Président chez OMNIAB, INC. Fortune : 12 M $ au 30/06/2026

Profil

John L.
Higgins is currently Chief Executive Officer at Metabasis Therapeutics, Inc. since 2010, Chief Executive Officer at CyDex Pharmaceuticals, Inc., Chairman at OmniAb Operations, Inc. since 2022, Chairman at Franklin Center (Minnesota), Chairman at OmniAb, Inc. since 2022, Independent Director at Bio-Techne Corp.
since 2009, and Director at The Pelican, Inc. since 2020.
Former roles include Director at BioCryst Pharmaceuticals, Inc. from 2004 to 2012, Director at Ligand Pharmaceuticals, Inc. until 2022, Director at CoMentis, Inc., Director at Blue Zones LLC, CFO & EVP-Administration & Corporate Development at Connetics Corp.
from 1997 to 2006, and Member of the Healthcare Banking Team at Dillon, Read & Co., Inc. Education includes undergraduate studies at Colgate University.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
OMNIAB, INC. 2,04 %	17/06/2026	2 962 320 ( 2,04 % )	7 M $	30/06/2026
BIO-TECHNE CORPORATION 0,04 %	30/10/2025	66 876 ( 0,04 % )	5 M $	30/06/2026

Postes actifs de John Higgins

Sociétés	Poste	Début
BIO-TECHNE CORPORATION	Directeur/Membre du Conseil	19/05/2009
PFENEX INC.	Directeur/Membre du Conseil	01/10/2020
OMNIAB, INC.	Président	01/11/2022
Metabasis Therapeutics, Inc.	Directeur Général	01/01/2010
OmniAb Operations, Inc.	Président	-
Academy of Whole Learning	Président	-
CyDex Pharmaceuticals, Inc.	Directeur Général	-

Anciens postes connus de John Higgins

Sociétés	Poste	Fin
LIGAND PHARMACEUTICALS INCORPORATED	Directeur Général	05/12/2022
BIOCRYST PHARMACEUTICALS, INC.	Directeur/Membre du Conseil	-
░░░░░░░░░ ░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░	░░░░░░░░░░
░░░░ ░░░░░ ░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-
░░░░░░░░░ ░░░░	░░░░░░░░░░	-